Department of Biomedical Sciences

Read more
6221 - 6230 out of 9,776Page size: 10
Sort by: 1st author
  1. Published

    Actions of glucagon-like peptide-1 receptor ligands in the gut

    Holst, Jens Juul, Andersen, Daniel Bjørklund & Grunddal, Kaare Villum, 2022, In: British Journal of Pharmacology. 179, 4, p. 727-742

    Research output: Contribution to journal › Review › Research › peer-review

  2. Published

    Is there a place for incretin therapies in obesity and prediabetes?

    Holst, Jens Juul & Deacon, Carolyn F., 13 Feb 2013, In: Trends in Endocrinology and Metabolism. 24, 3, p. 145-152 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    GLP-1 receptor agonists: targeting both hyperglycaemia and disease processes in diabetes

    Holst, Jens Juul & Seino, Y., 2009, In: Diabetes Research and Clinical Practice. 85, 1, p. 1-3 2 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    New Lessons from the gut: Studies of the role of gut peptides in weight loss and diabetes resolution after gastric bypass and sleeve gastrectomy

    Holst, Jens Juul, Madsbad, Sten, Bojsen-Møller, Kirstine Nyvold, Dirksen, C. & Svane, M., 2024, In: Peptides. 176, 9 p., 171199.

    Research output: Contribution to journal › Review › Research › peer-review

  5. Published

    Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus.

    Holst, Jens Juul & Deacon, Carolyn F., 2004, In: Current Opinion in Pharmacology. 4, 6, p. 589-96 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    The pathogenesis of non-insulin dependent diabetes mellitus involves a defective expression of the GIP receptor.

    Holst, Jens Juul, Gromada, J. L. & Nauck, M. A., 1997, In: Diabetologia. 40, p. 984-986

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Non-insulin-dependent diabetes mellitus - new drugs?

    Holst, Jens Juul, 1997, In: Drug Discovery Today. 2, p. 128-129

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Somatostatin is an essential paracrine link in acid inhibition of gastrin secretion

    Holst, Jens Juul, Ørskov, Cathrine & Poulsen, S. S., 1992, In: Digestion. 51, p. 95-102

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    What combines best with GLP-1 for obesity treatment: GIP receptor agonists or antagonists?

    Holst, Jens Juul, 2021, In: Cell Reports Medicine. 2, 5, 2 p., 100284.

    Research output: Contribution to journal › Comment/debate › Research

  10. Published

    Oxyntomodulin: actions and role in diabetes

    Holst, Jens Juul, Albrechtsen, Nicolai Jacob Wewer, Gabe, M. B. N. & Rosenkilde, M. M., 2018, In: Peptides. 100, p. 48-53 6 p.

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1...619 620 621 622 623 624 625 626 ...978 Next